These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 18041162

  • 1. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
    Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN, A-HeFT Investigators.
    Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
    [Abstract] [Full Text] [Related]

  • 2. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
    Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M, Adams K, Olukotun AY, Ofili E, Tam SW, Sabolinski ML, Worcel M, Cohn JN, African-American Heart Failure Trial Investigators.
    Circulation; 2007 Apr 03; 115(13):1747-53. PubMed ID: 17372175
    [Abstract] [Full Text] [Related]

  • 3. G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.
    McNamara DM, Taylor AL, Tam SW, Worcel M, Yancy CW, Hanley-Yanez K, Cohn JN, Feldman AM.
    JACC Heart Fail; 2014 Dec 03; 2(6):551-7. PubMed ID: 25306451
    [Abstract] [Full Text] [Related]

  • 4. A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.
    Cheng JW.
    Clin Ther; 2006 May 03; 28(5):666-78. PubMed ID: 16861089
    [Abstract] [Full Text] [Related]

  • 5. Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.
    Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN.
    J Am Coll Cardiol; 2007 Jan 02; 49(1):32-9. PubMed ID: 17207719
    [Abstract] [Full Text] [Related]

  • 6. The African American Heart Failure Trial: a clinical trial update.
    Taylor AL.
    Am J Cardiol; 2005 Oct 10; 96(7B):44-8. PubMed ID: 16226935
    [Abstract] [Full Text] [Related]

  • 7. African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology.
    Franciosa JA, Taylor AL, Cohn JN, Yancy CW, Ziesche S, Olukotun A, Ofili E, Ferdinand K, Loscalzo J, Worcel M, A-HeFT Investigators.
    J Card Fail; 2002 Jun 10; 8(3):128-35. PubMed ID: 12140804
    [Abstract] [Full Text] [Related]

  • 8. Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial.
    Anand IS, Win S, Rector TS, Cohn JN, Taylor AL.
    Circ Heart Fail; 2014 Sep 10; 7(5):759-65. PubMed ID: 24970468
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
    Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN, African-American Heart Failure Trial Investigators.
    N Engl J Med; 2004 Nov 11; 351(20):2049-57. PubMed ID: 15533851
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
    Colvin-Adams M, Taylor AL.
    Cleve Clin J Med; 2007 Mar 11; 74(3):227-34. PubMed ID: 17375804
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, Wander GS, Yap JJ, MacDonald MR, Xu CF, Chia YM, Shimizu W, ASIAN-HF investigators, Richards AM, Voors A, Lam CS.
    Lancet Glob Health; 2018 Sep 11; 6(9):e1008-e1018. PubMed ID: 30103979
    [Abstract] [Full Text] [Related]

  • 18. Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial.
    Chang KW, Beri N, Nguyen NH, Arbit B, Fox S, Mojaver S, Clopton P, Tam SW, Taylor AL, Cohn JN, Maisel AS, Anand IS.
    J Card Fail; 2018 May 11; 24(5):303-309. PubMed ID: 28918108
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
    Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF.
    Clin Ther; 2009 Mar 11; 31(3):632-43. PubMed ID: 19393854
    [Abstract] [Full Text] [Related]

  • 20. Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure.
    Ofili E, Anand I, Williams RA, Akinboboye O, Xu L, Puckrein G.
    Adv Ther; 2017 Aug 11; 34(8):1976-1988. PubMed ID: 28707284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.